New emerging targets in cancer immunotherapy: the role of Cluster of Differentiation 40 (CD40/TNFR5)

• Manuel Piechutta,
• Anna Sophie Berghoff

Affiliations

Manuel Piechutta

Clinical Cooperation Unit Neurooncology, German Cancer Research Centre, Heidelberg, Germany

Anna Sophie Berghoff

Department of Medicine I, Clinical Division of Oncology, Medical University of Vienna, Vienna, Austria